La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

Identifieur interne : 000921 ( PubMed/Curation ); précédent : 000920; suivant : 000922

Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

Auteurs : Ruth-Mary Desouza [Royaume-Uni] ; Elena Moro ; Anthony E. Lang ; Anthony H V. Schapira

Source :

RBID : pubmed:23483564

English descriptors

Abstract

We review the current application of deep brain stimulation (DBS) in Parkinson disease (PD) and consider the evidence that earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy. Electronic searches were performed of PubMed, Web of Knowledge, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials to identify all article types relating to the timing of DBS in PD. Current evidence suggests that DBS is typically performed in late stage PD, a mean of 14 to 15 years after diagnosis. Current guidelines recommend that PD patients who are resistant to medical therapies, have significant medication side effects and lengthening off periods, but are otherwise cognitively intact and medically fit for surgery be considered for DBS. If these criteria are rigidly interpreted, it may be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit for neurosurgical intervention. From the evidence available, we conclude that surgical management of PD alone or in combination with medical therapy results in greater improvement of motor symptoms and quality of life than medical treatment alone. There is evidence to support the use of DBS in less advanced PD and that it may be appropriate for earlier stages of the disease than for which it is currently used. The improving short and long-term safety profile of DBS makes early application a realistic possibility.

DOI: 10.1002/ana.23890
PubMed: 23483564

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:23483564

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?</title>
<author>
<name sortKey="Desouza, Ruth Mary" sort="Desouza, Ruth Mary" uniqKey="Desouza R" first="Ruth-Mary" last="Desouza">Ruth-Mary Desouza</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences, Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Moro, Elena" sort="Moro, Elena" uniqKey="Moro E" first="Elena" last="Moro">Elena Moro</name>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
</author>
<author>
<name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23483564</idno>
<idno type="pmid">23483564</idno>
<idno type="doi">10.1002/ana.23890</idno>
<idno type="wicri:Area/PubMed/Corpus">000921</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000921</idno>
<idno type="wicri:Area/PubMed/Curation">000921</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000921</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?</title>
<author>
<name sortKey="Desouza, Ruth Mary" sort="Desouza, Ruth Mary" uniqKey="Desouza R" first="Ruth-Mary" last="Desouza">Ruth-Mary Desouza</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences, Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Moro, Elena" sort="Moro, Elena" uniqKey="Moro E" first="Elena" last="Moro">Elena Moro</name>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
</author>
<author>
<name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
</author>
</analytic>
<series>
<title level="j">Annals of neurology</title>
<idno type="eISSN">1531-8249</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Databases, Factual (statistics & numerical data)</term>
<term>Deep Brain Stimulation (methods)</term>
<term>Deep Brain Stimulation (trends)</term>
<term>Humans</term>
<term>Parkinson Disease (therapy)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Deep Brain Stimulation</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Databases, Factual</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en">
<term>Deep Brain Stimulation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We review the current application of deep brain stimulation (DBS) in Parkinson disease (PD) and consider the evidence that earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy. Electronic searches were performed of PubMed, Web of Knowledge, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials to identify all article types relating to the timing of DBS in PD. Current evidence suggests that DBS is typically performed in late stage PD, a mean of 14 to 15 years after diagnosis. Current guidelines recommend that PD patients who are resistant to medical therapies, have significant medication side effects and lengthening off periods, but are otherwise cognitively intact and medically fit for surgery be considered for DBS. If these criteria are rigidly interpreted, it may be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit for neurosurgical intervention. From the evidence available, we conclude that surgical management of PD alone or in combination with medical therapy results in greater improvement of motor symptoms and quality of life than medical treatment alone. There is evidence to support the use of DBS in less advanced PD and that it may be appropriate for earlier stages of the disease than for which it is currently used. The improving short and long-term safety profile of DBS makes early application a realistic possibility.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23483564</PMID>
<DateCreated>
<Year>2013</Year>
<Month>06</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2013</Year>
<Month>08</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1531-8249</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>73</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2013</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Annals of neurology</Title>
<ISOAbbreviation>Ann. Neurol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?</ArticleTitle>
<Pagination>
<MedlinePgn>565-75</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.23890</ELocationID>
<Abstract>
<AbstractText>We review the current application of deep brain stimulation (DBS) in Parkinson disease (PD) and consider the evidence that earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy. Electronic searches were performed of PubMed, Web of Knowledge, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials to identify all article types relating to the timing of DBS in PD. Current evidence suggests that DBS is typically performed in late stage PD, a mean of 14 to 15 years after diagnosis. Current guidelines recommend that PD patients who are resistant to medical therapies, have significant medication side effects and lengthening off periods, but are otherwise cognitively intact and medically fit for surgery be considered for DBS. If these criteria are rigidly interpreted, it may be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit for neurosurgical intervention. From the evidence available, we conclude that surgical management of PD alone or in combination with medical therapy results in greater improvement of motor symptoms and quality of life than medical treatment alone. There is evidence to support the use of DBS in less advanced PD and that it may be appropriate for earlier stages of the disease than for which it is currently used. The improving short and long-term safety profile of DBS makes early application a realistic possibility.</AbstractText>
<CopyrightInformation>© 2013 American Neurological Association.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>deSouza</LastName>
<ForeName>Ruth-Mary</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moro</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lang</LastName>
<ForeName>Anthony E</ForeName>
<Initials>AE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schapira</LastName>
<ForeName>Anthony H V</ForeName>
<Initials>AH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>089698</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_G1000735</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Neurol</MedlineTA>
<NlmUniqueID>7707449</NlmUniqueID>
<ISSNLinking>0364-5134</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurol. 2012 Jan;19(1):121-7</RefSource>
<PMID Version="1">21668586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Feb 15;23(3):343-9</RefSource>
<PMID Version="1">17987644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsons Dis. 2011 Feb 20;2011:658415</RefSource>
<PMID Version="1">21403902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Jun;21 Suppl 14:S290-304</RefSource>
<PMID Version="1">16892449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurol. 2009 Feb;16(2):194-200</RefSource>
<PMID Version="1">19146640</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Oct;26 Suppl 3:S2-41</RefSource>
<PMID Version="1">22021173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2009 Aug 15;24(11):1613-20</RefSource>
<PMID Version="1">19533754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1994 Aug;72(2):521-30</RefSource>
<PMID Version="1">7983516</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2004 Jun;55(6):871-5</RefSource>
<PMID Version="1">15174022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosurg. 2005 Dec;103(6):968-73</RefSource>
<PMID Version="1">16381182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2006 Oct;129(Pt 10):2667-78</RefSource>
<PMID Version="1">16844713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurgery. 2011 Aug;69(2):357-60; discussion 360-1</RefSource>
<PMID Version="1">21415789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2010 Jun 3;362(22):2077-91</RefSource>
<PMID Version="1">20519680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuropsychiatry Clin Neurosci. 2009 Fall;21(4):398-405</RefSource>
<PMID Version="1">19996248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):694-9</RefSource>
<PMID Version="1">17898034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2007 Sep;13 Suppl:S8-S12</RefSource>
<PMID Version="1">17702630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2004 Jan 13;62(1 Suppl 1):S1-8</RefSource>
<PMID Version="1">14718675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neural Transm Suppl. 2006;(70):409-14</RefSource>
<PMID Version="1">17017560</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2008 Dec;64 Suppl 2:S56-64</RefSource>
<PMID Version="1">19127577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2002 Jun;249(6):759-66</RefSource>
<PMID Version="1">12111311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosurg. 2004 Apr;100(4):679-87</RefSource>
<PMID Version="1">15070123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2013 Feb 14;368(7):610-22</RefSource>
<PMID Version="1">23406026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2006 Oct 5;52(1):197-204</RefSource>
<PMID Version="1">17015236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2001 Oct;171(2):405-17</RefSource>
<PMID Version="1">11573992</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2009 Feb 17;72(7 Suppl):S65-73</RefSource>
<PMID Version="1">19221317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 Sep;133(9):2664-76</RefSource>
<PMID Version="1">20802207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Manag Care. 2010 Mar;16 Suppl Implications:S87-93</RefSource>
<PMID Version="1">20297871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Neurosci. 2011 Jun;18(6):804-6</RefSource>
<PMID Version="1">21489800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Jul 30;25(10):1456-63</RefSource>
<PMID Version="1">20629150</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Jan 30;68(5):384-6</RefSource>
<PMID Version="1">17082464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2008 Jul;7(7):605-14</RefSource>
<PMID Version="1">18538636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Integr Neurosci. 2011 May 16;5:19</RefSource>
<PMID Version="1">21779238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurol Scand. 2011 Sep;124(3):211-4</RefSource>
<PMID Version="1">20969559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Apr 30;23(6):837-44</RefSource>
<PMID Version="1">18307261</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2008 Oct;131(Pt 10):2720-8</RefSource>
<PMID Version="1">18941146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2011 Jul;17(6):413-7</RefSource>
<PMID Version="1">21382739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosurg. 2012 Jun;116(6):1347-56</RefSource>
<PMID Version="1">22424564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Nov;26(13):2303-4</RefSource>
<PMID Version="1">22109849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Geriatr Psychiatry. 2009 May;24(5):443-51</RefSource>
<PMID Version="1">19016252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>No To Shinkei. 2005 Jun;57(6):495-8</RefSource>
<PMID Version="1">16026045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Sep 15;22(12):1722-8</RefSource>
<PMID Version="1">17721929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2000 Apr;57(4):461-5</RefSource>
<PMID Version="1">10768618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2011 Feb;68(2):165</RefSource>
<PMID Version="1">20937936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Sci. 2008 Oct 15;273(1-2):19-24</RefSource>
<PMID Version="1">18640690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Aug 15;25(11):1530-7</RefSource>
<PMID Version="1">20544809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2008 May;131(Pt 5):1373-80</RefSource>
<PMID Version="1">18400841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Nov 15;22(15):2183-91</RefSource>
<PMID Version="1">17724747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2006 Mar;59(3):559-62</RefSource>
<PMID Version="1">16489611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2006 May 9;66(9):1451-2</RefSource>
<PMID Version="1">16682687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S165-7</RefSource>
<PMID Version="1">22166422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2010 Jun;9(6):581-91</RefSource>
<PMID Version="1">20434403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2011 Dec;68(12):1550-6</RefSource>
<PMID Version="1">21825213</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2003 Jan;18(1):19-31</RefSource>
<PMID Version="1">12518297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Asian J Surg. 2009 Oct;32(4):258-63</RefSource>
<PMID Version="1">19892631</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Neuropsychol Soc. 2007 Jan;13(1):68-79</RefSource>
<PMID Version="1">17166305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2010 Jul;39(1):105-15</RefSource>
<PMID Version="1">20307668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):251-7</RefSource>
<PMID Version="1">22180646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurol India. 2008 Oct-Dec;56(4):474-6</RefSource>
<PMID Version="1">19127045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2006 Aug 31;355(9):896-908</RefSource>
<PMID Version="1">16943402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2007 Dec;13(8):528-31</RefSource>
<PMID Version="1">17347021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2011 Mar;17(3):182-8</RefSource>
<PMID Version="1">21256069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2010 Jun;16(5):338-44</RefSource>
<PMID Version="1">20227323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2013 Jan;19(1):56-61</RefSource>
<PMID Version="1">22841616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychology. 2010 Jan;24(1):1-8</RefSource>
<PMID Version="1">20063943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):164-70</RefSource>
<PMID Version="1">21890575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 Apr;133(Pt 4):1111-27</RefSource>
<PMID Version="1">20237128</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1217-21</RefSource>
<PMID Version="1">16107354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Nov;26(13):2327-34</RefSource>
<PMID Version="1">22012750</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2009 Jan;256(1):83-8</RefSource>
<PMID Version="1">19221846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurol. 2009 Apr;16(4):450-6</RefSource>
<PMID Version="1">19187262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2008 Mar;210(1):257-60</RefSource>
<PMID Version="1">18036524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2003 Nov 13;349(20):1925-34</RefSource>
<PMID Version="1">14614167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2002;17 Suppl 3:S94-101</RefSource>
<PMID Version="1">11948762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):443-9</RefSource>
<PMID Version="1">16543519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ther Adv Neurol Disord. 2011 Jan;4(1):15-24</RefSource>
<PMID Version="1">21339905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2004 Jun;3(6):362-8</RefSource>
<PMID Version="1">15157851</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2012 Jul 3;79(1):55-65</RefSource>
<PMID Version="1">22722632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2009 Jan 7;301(1):63-73</RefSource>
<PMID Version="1">19126811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacoeconomics. 2011 Dec;29(12):1025-49</RefSource>
<PMID Version="1">22077577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2008 Dec;64 Suppl 2:S101-10</RefSource>
<PMID Version="1">19127580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2003 Jan 14;60(1):78-81</RefSource>
<PMID Version="1">12525722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2011 Sep;17(8):606-9</RefSource>
<PMID Version="1">21669545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Med Res. 2009 May-Jun;37(3):717-26</RefSource>
<PMID Version="1">19589255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2010 Jun;16(6):653-61</RefSource>
<PMID Version="1">20495568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Apr 15;25(5):578-86</RefSource>
<PMID Version="1">20213817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurol. 2010 Jun;6(6):309-17</RefSource>
<PMID Version="1">20479780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2011 Apr;258(4):641-6</RefSource>
<PMID Version="1">21088849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2012 Feb;11(2):140-9</RefSource>
<PMID Version="1">22239915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Jun;21 Suppl 14:S171-96</RefSource>
<PMID Version="1">16810718</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Jan 23;68(4):267-71</RefSource>
<PMID Version="1">17151341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2006 Mar;5(3):235-45</RefSource>
<PMID Version="1">16488379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2009 May;65(5):586-95</RefSource>
<PMID Version="1">19288469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2009 Aug;256(8):1321-9</RefSource>
<PMID Version="1">19363633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Neurophysiol. 2009 Sep;120(9):1755-61</RefSource>
<PMID Version="1">19632151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Apr 24;68(17):1345-55</RefSource>
<PMID Version="1">17452578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Manag Care. 2008 Mar;14(2 Suppl):S40-8</RefSource>
<PMID Version="1">18402507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 2009 Aug 25;1286:230-8</RefSource>
<PMID Version="1">19563788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1186-7</RefSource>
<PMID Version="1">16107346</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2007 Oct;6(10):926-32</RefSource>
<PMID Version="1">17884682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2006 Jul;63(7):951-5</RefSource>
<PMID Version="1">16831963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2001 Jan;16(1):166-8</RefSource>
<PMID Version="1">11215582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2008 Dec;131(Pt 12):3348-60</RefSource>
<PMID Version="1">18842609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2009 Dec;15(10):746-51</RefSource>
<PMID Version="1">19481492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2004 Jan;24(1):7-16</RefSource>
<PMID Version="1">14688612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Clin Pract Neurol. 2008 Aug;4(8):424-6</RefSource>
<PMID Version="1">18594505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurgery. 2005 Jun;56(6):1313-21; discussion 1321-4</RefSource>
<PMID Version="1">15918948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2009 Jan 6;72(1):42-9</RefSource>
<PMID Version="1">19122029</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Rev Neurother. 2006 Nov;6(11):1695-705</RefSource>
<PMID Version="1">17144783</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Sep 15;22(12):1729-34</RefSource>
<PMID Version="1">17557355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurol. 2010 Sep;17(9):1156-63</RefSource>
<PMID Version="1">20345926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2007 Aug;130(Pt 8):2129-45</RefSource>
<PMID Version="1">17584773</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046690" MajorTopicYN="N">Deep Brain Stimulation</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4065356</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2013</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>03</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>3</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>3</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23483564</ArticleId>
<ArticleId IdType="doi">10.1002/ana.23890</ArticleId>
<ArticleId IdType="pmc">PMC4065356</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000921 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000921 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:23483564
   |texte=   Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:23483564" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022